Welcome to our dedicated page for TERADYNE SEC filings (Ticker: TER), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on TERADYNE's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into TERADYNE's regulatory disclosures and financial reporting.
TERADYNE, INC (TER) director Mercedes Johnson reported selling common stock and updating her holdings. On September 1, 2026, she sold 167 shares of common stock at $341.30 per share in an open-market or private transaction pursuant to a Rule 10b5-1 trading plan adopted on March 4, 2026. After this sale, she held 6,364 shares directly and 1,876 shares indirectly through The Mercedes Johnson Trust UAD 07/23/04, where she is trustee and sole beneficiary.
TERADYNE, INC (TER) is the issuer for which director Mercedes Johnson has filed a notice of proposed sale of restricted securities under Rule 144. The filing covers the planned sale of 167 shares of common stock, originally acquired on May 10, 2016 through restricted stock vesting as compensation from the issuer.
The notice lists Fidelity Brokerage Services LLC as the broker and reports an approximate aggregate market value of 56997.10 for the 167 shares based on a price as of September 1, 2026. Johnson also reports prior Rule 144 sales over the past three months, each involving roughly 166–167 shares of TER common stock.
TERADYNE, INC (TER) director and President & CEO Gregory Stephen Smith reported selling 4,000 shares of common stock on August 17, 2026 at $425.00 per share. Following this sale, he holds 112,495.4075 shares directly. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted on February 12, 2026.
TERADYNE, INC (TER) director Marilyn Matz reported selling 1,200 shares of common stock on August 17, 2026 at $425.00 per share in an open-market or private transaction. After this sale, she directly holds 15,040.675 shares. The transaction was executed under a Rule 10b5-1 trading plan adopted on February 13, 2026.
Teradyne, Inc. insider Marilyn Matz has filed a Form 144 notice for the proposed sale of 1,200 shares of Teradyne common stock through Fidelity Brokerage Services LLC on or about August 17, 2026, to be sold on the NASDAQ. These shares were acquired from the issuer as restricted stock vesting on May 7, 2021 as compensation. The filing also lists prior Teradyne share sales by Matz during the past three months.
Teradyne, Inc. (TER) reporting person Gregory S. Smith has notified an intention to sell 4,000 shares of common stock through Fidelity Brokerage Services, with an indicated aggregate market value of $1,700,000.00 as of a planned sale date of 08/17/2026. The shares derive from restricted stock vesting received as compensation on 01/27/2026. Smith also reports prior open-market sales of 4,000 shares on 06/15/2026 for $1,692,120.00 and 4,000 shares on 07/15/2026 for $1,425,240.00.
Teradyne, Inc. entered into a new Credit Agreement with PNC Bank, National Association and a syndicate of lenders providing a five-year, senior secured revolving credit facility of $1.0 billion. Proceeds may be used for working capital and general corporate purposes, and no amounts are currently outstanding.
Loans under the facility bear interest, at Teradyne’s option, at a base rate plus a margin of 0.00%–0.75% per year or SOFR plus 1.00%–1.75% per year, depending on the consolidated leverage ratio, with reduced margins of up to 0.50% over base or 1.50% over SOFR during an Investment Grade Suspension Period. Teradyne will also pay a commitment fee of 0.125%–0.225% per year on unused commitments, or 0.10%–0.20% during an Investment Grade Suspension Period.
The facility is guaranteed by certain wholly owned domestic subsidiaries and secured by Teradyne’s and such subsidiaries’ assets, including a pledge of 65% of the capital stock of certain foreign subsidiaries. Financial covenants include a maximum consolidated leverage ratio of 3.50:1.00 (temporarily 4.00:1.00 following large acquisitions) and, outside an Investment Grade Suspension Period, a minimum interest coverage ratio of 2.50:1.00. Collateral, guarantees and certain restrictive covenants are suspended upon achieving specified investment grade ratings and can be reinstated if ratings are later downgraded.
Teradyne, Inc. director Mercedes Johnson reported selling 166 shares of common stock on August 3, 2026 at $358.15 per share in an open-market or private transaction under a Rule 10b5-1 trading plan adopted March 4, 2026. She now holds 6,531 shares directly and 1,876 shares indirectly through a trust.
Teradyne, Inc. insider Mercedes Johnson filed a Form 144 covering a proposed resale of 166 shares of common stock through Fidelity Brokerage Services LLC on or after August 3, 2026 on NASDAQ, with an indicated value of $59,452.90.
The shares derive from restricted stock vesting on May 10, 2016 as compensation. The filing also lists prior sales in the last three months of 167 shares on June 2, 2026 for $61,746.58 and 167 shares on July 1, 2026 for $76,820.00.
Teradyne, Inc., a provider of automated test equipment and robotics solutions, reported sharply higher results for the quarter ended June 28, 2026. Total revenues were $1,328,990 thousand, up from $651,797 thousand a year earlier, with both products and services contributing to the increase. Income from operations was $437,810 thousand versus $90,743 thousand, and net income attributable to Teradyne reached $374,533 thousand, compared with $78,372 thousand. Diluted earnings per share were $2.38, up from $0.49.
For the first six months of 2026, revenues were $2,611,484 thousand and net income attributable to Teradyne was $773,442 thousand, with diluted EPS of $4.91. Operating cash flow rose to $734,262 thousand, allowing repayment of $200,000 thousand of short-term debt and ending cash and cash equivalents at $349,538 thousand.
Teradyne completed the $157,839 thousand acquisition of a 75% interest in MultiLane Test Products Holding LLP, recording $131,634 thousand of goodwill and $46,700 thousand of intangible assets in its Product Test segment. The equity method investment in Technoprobe had a carrying value of $514,957 thousand, compared with a quoted fair value of $2,457.9 million.